292 related articles for article (PubMed ID: 34082120)
1. Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages.
Chiu PJ; Rathod J; Hong YP; Tsai PJ; Hung YP; Ko WC; Chen JW; Paredes-Sabja D; Huang IH
Anaerobe; 2021 Aug; 70():102381. PubMed ID: 34082120
[TBL] [Abstract][Full Text] [Related]
2. Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling.
Chen X; Yang X; de Anda J; Huang J; Li D; Xu H; Shields KS; Džunková M; Hansen J; Patel IJ; Yee EU; Golenbock DT; Grant MA; Wong GCL; Kelly CP
Gastroenterology; 2020 Dec; 159(6):2181-2192.e1. PubMed ID: 32841647
[TBL] [Abstract][Full Text] [Related]
3. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
Wang S; Heuler J; Wickramage I; Sun X
Microbiol Spectr; 2022 Apr; 10(2):e0178821. PubMed ID: 35315695
[TBL] [Abstract][Full Text] [Related]
4. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL
PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843
[TBL] [Abstract][Full Text] [Related]
5. Nasal Immunization with the C-Terminal Domain of Bcla3 Induced Specific IgG Production and Attenuated Disease Symptoms in Mice Infected with
Maia AR; Reyes-Ramírez R; Pizarro-Guajardo M; Saggese A; Ricca E; Baccigalupi L; Paredes-Sabja D
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933117
[No Abstract] [Full Text] [Related]
6. Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile.
Cowardin CA; Kuehne SA; Buonomo EL; Marie CS; Minton NP; Petri WA
mBio; 2015 Jan; 6(1):. PubMed ID: 25626905
[TBL] [Abstract][Full Text] [Related]
7.
Zhu D; Sorg JA; Sun X
Front Cell Infect Microbiol; 2018; 8():29. PubMed ID: 29473021
[No Abstract] [Full Text] [Related]
8. Combined and Distinct Roles of Agr Proteins in Clostridioides difficile 630 Sporulation, Motility, and Toxin Production.
Ahmed UKB; Shadid TM; Larabee JL; Ballard JD
mBio; 2020 Dec; 11(6):. PubMed ID: 33443122
[TBL] [Abstract][Full Text] [Related]
9. Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.
Hong HA; Hitri K; Hosseini S; Kotowicz N; Bryan D; Mawas F; Wilkinson AJ; van Broekhoven A; Kearsey J; Cutting SM
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167669
[TBL] [Abstract][Full Text] [Related]
10. Enterotoxic Clostridia:
Mileto S; Das A; Lyras D
Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31124432
[No Abstract] [Full Text] [Related]
11. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
12. Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages.
Sun X; He X; Tzipori S; Gerhard R; Feng H
Microb Pathog; 2009 Jun; 46(6):298-305. PubMed ID: 19324080
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile spore-macrophage interactions: spore survival.
Paredes-Sabja D; Cofre-Araneda G; Brito-Silva C; Pizarro-Guajardo M; Sarker MR
PLoS One; 2012; 7(8):e43635. PubMed ID: 22952726
[TBL] [Abstract][Full Text] [Related]
14. Redistribution of the Novel Clostridioides difficile Spore Adherence Receptor E-Cadherin by TcdA and TcdB Increases Spore Binding to Adherens Junctions.
Castro-Córdova P; Otto-Medina M; Montes-Bravo N; Brito-Silva C; Lacy DB; Paredes-Sabja D
Infect Immun; 2023 Jan; 91(1):e0047622. PubMed ID: 36448839
[TBL] [Abstract][Full Text] [Related]
15.
Coullon H; Rifflet A; Wheeler R; Janoir C; Boneca IG; Candela T
J Biol Chem; 2018 Nov; 293(47):18040-18054. PubMed ID: 30266804
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of bile salts in mice influences spore germination in Clostridium difficile.
Giel JL; Sorg JA; Sonenshein AL; Zhu J
PLoS One; 2010 Jan; 5(1):e8740. PubMed ID: 20090901
[TBL] [Abstract][Full Text] [Related]
17. The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility.
Amadou Amani S; Lang GA; Ballard JD; Lang ML
Infect Immun; 2021 Sep; 89(10):e0027421. PubMed ID: 34097471
[TBL] [Abstract][Full Text] [Related]
18. A 3D intestinal tissue model supports Clostridioides difficile germination, colonization, toxin production and epithelial damage.
Shaban L; Chen Y; Fasciano AC; Lin Y; Kaplan DL; Kumamoto CA; Mecsas J
Anaerobe; 2018 Apr; 50():85-92. PubMed ID: 29462695
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy induced by recombinant Clostridium difficile toxin fragments.
Leuzzi R; Spencer J; Buckley A; Brettoni C; Martinelli M; Tulli L; Marchi S; Luzzi E; Irvine J; Candlish D; Veggi D; Pansegrau W; Fiaschi L; Savino S; Swennen E; Cakici O; Oviedo-Orta E; Giraldi M; Baudner B; D'Urzo N; Maione D; Soriani M; Rappuoli R; Pizza M; Douce GR; Scarselli M
Infect Immun; 2013 Aug; 81(8):2851-60. PubMed ID: 23716610
[TBL] [Abstract][Full Text] [Related]
20. Equine hyperimmune serum protects mice against Clostridium difficile spore challenge.
Yan W; Shin KS; Wang SJ; Xiang H; Divers T; McDonough S; Bowman J; Rowlands A; Akey B; Mohamed H; Chang YF
J Vet Sci; 2014; 15(2):249-58. PubMed ID: 24136208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
